Onassis Launches Sales of Top of Line Extrax CBD Vapes
December 13th, 2021
NEW YORK, Dec. 13, 2021 /PRNewswire/ — Onassis Holding Corp, (OTC: ONSS), a wellness holding company specializing in healthcare, technology and the distribution of nutraceuticals and herbal-based medications, has launched sales of the Extrax CBD vape formulations.
The formulations were developed in the UK and is particularly unique, offering five different mood experiences.
All of Onassis’ marketing operations of Extrax will be carried out by Ananda Labs Inc., a US subsidiary of Onassis. The Extrax vapes will be added to The Company’s wide range of wellness products and will be sold in the EU and North America.
Prior to launching sales, Onassis performed extensive lab tests over the past year. The lab results were extremely positive leading Onassis to open a unique store for CBD Vapes.
The Extrax development team believes that we can master our mood and improve our lives with the support of natural extracts. Extrax’s first product, a CBD vape, is called “The Evolution of Inhalation”.
Vaping is an easy, effective way to use CBD for body and mind wellness and has a range of benefits. In the case of vaping, the CBD absorption is very high, as inhaling bypasses the digestive tract and sends CBD into the lungs and directly in the bloodstream in a short time, with maximum effect.
The Extrax vape formula is straightforward. It comes with broad-spectrum CBD Hemp extract combined with Cannabis derived terpenes, in high-quality vaping devices, without any stabilisers or additives of any sort, which creates a new market level of vaping by setting a new “vaping smart” trend.
Broad-spectrum CBD (Cannabidiol) hemp extract contains a wide variety of naturally occurring cannabinoids which, together with terpenes and flavonoids, make it capable of the “Entourage Effect”. This effect happens when all elements in the hemp extract work stronger together to provide maximum effect and create powerful, holistic results.
Every CBD Vape formulation contains 320mg CBD and 80% cannabinoids in total, and blended with unique cannabis derived terpenes, which gives vape products flavours of famous Cannabis strains, such as; Lemon Cake, Pina Colada, Mango Kush, Strawberry Fields and Blueberry Shot.
EXTRAX vape products have premium design and reliable ceramic heating elements that gives an exceptional experience, where high-end technology merges with extensively safe and researched natural ingredients.
EXTRAX Ltd is a U.K. based wellness company, developing and supplying premium plant-based products enhanced with innovative technologies. The Company was founded by a team of experts involved in developing different Hemp-based herbal products and plant extracts for over five years. Their experience shows that plants have the most far-reaching, positive, and well-documented impact on the human body. The Company operates with an ongoing agenda to rediscover these compounds in plants and bring them to our lives through modern technologies in the shape of easy-to use wellness products.
About Onassis Holdings Corp
A wellness holding company specializing in healthcare, technology and the distribution of nutraceuticals and herbal-based medications.
The Company is currently focused on distribution of nutraceuticals and herbal-based medications in the wellness sector, along with future plans for manufacturing new products for this market. Onassis has begun working with the world’s top nutrition experts for innovative manufacturing and marketing collaboration. The Company has selected products that passed in-vitro and in-vivo clinical studies of herbal and marine formulations utilized and documented by traditional and natural medicine in over thousand years to ensure that our ingredients are effective. Our herbs are hand-selected and reasonably sourced only from authentic medicinal material cultivation areas, designed to be fully traceable from harvest to extract.
Onassis Holdings is headquartered in New York City, with its warehouse and fulfillment offices located in Long Island, New York. Onassis originally incorporated in 2004 in the State of Nevada.
CimetrA- IMP -Investigational Medicinal Product under urgent registration process in the US to treat Covid-19 Corona Virus.
Co-Blox – Food supplement capsule to boost the immune system.
Majestix – Syrup made of 15 plant extracts
Majestix Post- Syrup made of 15 plant extracts, Vitamins and Fungus.
ArtemiC Rescue – This is a food supplement intended to support the immune system, containing four ingredients consisting of artemisinin, Curcuma longa L. Rhizome extract, Boswellia serrata oleo resin, and L-ascorbic acid (Vitamin C).
Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the actual results of the Company to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “should,” “intends,” “will,” or “plans” to be uncertain and forward-looking.
For more information about Onassis:
Onassis Holdings Corp.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.